Pear Therapeutics, Inc. today announced management’s participation in three virtual investor conferences in October 2020:
Cowen 9th Annual MedTools Conference – Answers Unlocked. Corey McCann, M.D., Ph.D., President and CEO, will participate in a panel discussion, Digital Therapeutics, at this virtual conference on Thursday, October 15, 2020 at 8:30 a.m. ET.
7th Solebury Trout Private Company Showcase Co-Hosted by BMO and Davis Polk. Corey McCann will present at this virtual conference on Thursday, October 15, 2020 at 11:40 a.m. ET.
HLTH VRTL 2020 Conference – Evercore ISI Panel Series Digging into Digital Therapeutics: A New Dimension in Treatment. Corey McCann will participate in a panel discussion, CEOs on DTx, at this virtual conference on Friday, October 16, 2020 at 11:00 a.m. ET.
Pear Therapeutics is a privately held, prescription digital therapeutics company developing clinically validated, FDA-authorized software applications to treat serious disease.
About Pear Therapeutics